Opinicus Capital Inc. Has $1.07 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Opinicus Capital Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% in the first quarter, HoldingsChannel reports. The firm owned 2,168 shares of the healthcare conglomerate’s stock after selling 35 shares during the period. Opinicus Capital Inc.’s holdings in UnitedHealth Group were worth $1,073,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of UnitedHealth Group by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 83,860,515 shares of the healthcare conglomerate’s stock valued at $44,150,045,000 after purchasing an additional 250,291 shares during the period. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after buying an additional 527,526 shares during the last quarter. Capital Research Global Investors grew its stake in shares of UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after acquiring an additional 324,733 shares during the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 4.8% during the 4th quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after purchasing an additional 542,424 shares during the last quarter. Finally, Norges Bank bought a new position in shares of UnitedHealth Group during the 4th quarter worth about $5,802,231,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.7 %

Shares of UNH opened at $509.26 on Friday. The firm has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.13, a PEG ratio of 1.48 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The business’s fifty day moving average price is $498.34 and its two-hundred day moving average price is $501.96.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the previous year, the business posted $6.26 EPS. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, analysts predict that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on UNH shares. TD Cowen lowered their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Bank of America reaffirmed a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research report on Thursday, March 7th. JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.